Showing results (151-160 of 192) with videos related to
Sort By:
Pageof 20
Cancer Research|February 22, 2012
miRNA signatures associate with pathogenesis and progression of osteosarcomaKevin B Jones, Zaidoun Salah, Sara Del Mare, et al.International Journal of Radiation Oncology, Biology, Physics|October 27, 2022
Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology GroupSafia K Ahmed, Brent G Witten, William S Harmsen, et al.Nature Medicine|October 25, 2011
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesYoko S DeRose, Guoying Wang, Yi-Chun Lin, et al.International Journal of Radiation Oncology, Biology, Physics|October 2, 2017
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology GroupSafia K Ahmed, R Lor Randall, Steven G DuBois, et al.European Journal of Cancer (Oxford, England : 1990)|July 9, 2022
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Mark Krailo, Allen Buxton, et al.Plos One|August 6, 2014
Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology GroupMichael J Monument, Kirsten M Johnson, Elizabeth McIlvaine, et al.Oncotarget|August 11, 2015
β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transitionJared J Barrott, Benjamin E Illum, Huifeng Jin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology GroupKatherine A Janeway, Alexander J Chou, Allen Buxton, et al.Journal of the National Cancer Institute|June 26, 2024
Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group reportLenka Ilcisin, Ruxu Han, Mark Krailo, et al.Journal of Surgical Oncology|February 13, 2023
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG OncologyMark L Kayton, Aaron R Weiss, Wei Xue, et al.Pageof 20